John J.V. McMurray

351.6k total citations · 79 hit papers
1.5k papers, 131.6k citations indexed

About

John J.V. McMurray is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Pulmonary and Respiratory Medicine. According to data from OpenAlex, John J.V. McMurray has authored 1.5k papers receiving a total of 131.6k indexed citations (citations by other indexed papers that have themselves been cited), including 1.1k papers in Cardiology and Cardiovascular Medicine, 373 papers in Endocrinology, Diabetes and Metabolism and 184 papers in Pulmonary and Respiratory Medicine. Recurrent topics in John J.V. McMurray's work include Heart Failure Treatment and Management (820 papers), Cardiovascular Function and Risk Factors (527 papers) and Diabetes Treatment and Management (252 papers). John J.V. McMurray is often cited by papers focused on Heart Failure Treatment and Management (820 papers), Cardiovascular Function and Risk Factors (527 papers) and Diabetes Treatment and Management (252 papers). John J.V. McMurray collaborates with scholars based in United Kingdom, United States and Canada. John J.V. McMurray's co-authors include Karl Swedberg, Marc A. Pfeffer, Scott D. Solomon, Simon Stewart, Salim Yusuf, Eric L. Michelson, Michael R. Zile, Christopher B. Granger, Milton Packer and Lars Køber and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

John J.V. McMurray

1.4k papers receiving 127.2k citations

Hit Papers

Randomised trial of cholesterol lowering in 4444 patients... 1994 2026 2004 2015 1994 2014 2020 2010 2003 2.0k 4.0k 6.0k

Peers

John J.V. McMurray
Comparison fields: 5 of 204
  • Cardiology and Cardiovascular Medicine 87.0k
  • Endocrinology, Diabetes and Metabolism 30.4k
  • Surgery 22.7k
  • Pulmonary and Respiratory Medicine 16.5k
  • Molecular Biology 13.3k
Salim Yusuf Canada
Daniel Levy United States
Marc A. Pfeffer United States
Deepak L. Bhatt United States
Peter W.F. Wilson United States
Scott D. Solomon United States
Ramachandran S. Vasan United States
Gregg C. Fonarow United States
William B. Kannel United States
Martin G. Larson United States
Salim Yusuf Canada View profile →
Citations per field, relative to John J.V. McMurray
John J.V. McMurray · 1×
Citations per year, relative to John J.V. McMurray
John J.V. McMurray · 1×

Countries citing papers authored by John J.V. McMurray

Since Specialization
Citations

This map shows the geographic impact of John J.V. McMurray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John J.V. McMurray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John J.V. McMurray more than expected).

Fields of papers citing papers by John J.V. McMurray

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John J.V. McMurray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John J.V. McMurray. The network helps show where John J.V. McMurray may publish in the future.

Co-authorship network of co-authors of John J.V. McMurray

This figure shows the co-authorship network connecting the top 25 collaborators of John J.V. McMurray. A scholar is included among the top collaborators of John J.V. McMurray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John J.V. McMurray. John J.V. McMurray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Title Journal Authors Indexed citations
1 Effects of Sacubitril/Valsartan According to Natriuretic Peptide Levels in Patients Enrolled in PARADIGM-HF and PARAGON-HF JACC Heart Failure Toru Kondo, Pardeep S. Jhund et al. 2
2 Natriuretic Peptides, Kidney Function, and Clinical Outcomes in Heart Failure With Preserved Ejection Fraction JACC Heart Failure Brendon L. Neuen, Muthiah Vaduganathan et al. 8
3 Sacubitril/Valsartan in Patients With Heart Failure and Deterioration in eGFR to <30 mL/min/1.73 m2 JACC Heart Failure Safia Chatur, Iris E. Beldhuis et al. 5
4 Race in Heart Failure JACC Heart Failure Henri Lu, Brian Claggett et al. 0
5 Sacubitril/Valsartan-Related Hypotension in Patients With Heart Failure and Preserved or Mildly Reduced Ejection Fraction Journal of the American College of Cardiology Alberto Foà, Muthiah Vaduganathan et al. 3
6 Association of CA-125 with markers of congestion, and effect of empagliflozin on CA-125 in patients with type 2 diabetes, or prediabetes, and heart failure with reduced ejection fraction (SUGAR-DM-HF) European Heart Journal Matthew M.Y. Lee, Paul Welsh et al. 0
7 The Heart Failure and Optimal Outcomes from Pharmacy Study (HOOPS): Rationale, Design, and Baseline Characteristics European Journal of Heart Failure Richard Lowrie, Frances S Mair et al. 11
8 Neurohumoral Effects of Aliskiren in Patients with Symptomatic Heart Failure Receiving a Mineralocorticoid Receptor Antagonist: The Aliskiren Observation of Heart Failure Treatment Study European Journal of Heart Failure Bertram Pitt, Roberto Latini et al. 20
9 Improved Survival with Bisoprolol in Patients with Heart Failure and Renal Impairment: An Analysis of the Cardiac Insufficiency Bisoprolol Study II (CIBIS-II) Trial European Journal of Heart Failure Davide Castagno, Pardeep S. Jhund et al. 62
10 The Inter-Relationship of Diabetes and Left Ventricular Systolic Function on Outcome After High-Risk Myocardial Infarction European Journal of Heart Failure Amil M. Shah, Hajime Uno et al. 39
11 Rationale and Design of the Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure (EMPHASIS-HF) European Journal of Heart Failure Faı̈ez Zannad, John J.V. McMurray et al. 56
12 The Prognostic Significance of Heart Failure with Preserved Left Ventricular Ejection Fraction: A Literature-Based Meta-Analysis European Journal of Heart Failure J. Somaratne, Colin Berry et al. 109
13 An Economic Evaluation of Rosuvastatin Treatment in Systolic Heart Failure: Evidence from the CORONA Trial European Journal of Heart Failure Paula Lorgelly, Andrew Briggs et al. 14
14 Heart Failure and Chronic Obstructive Pulmonary Disease: Lung Function Test Interpretation: Reply European Journal of Heart Failure Nathaniel M. Hawkins, Mark C. Petrie et al. 0
15 Heart Failure and Chronic Obstructive Pulmonary Disease: Diagnostic Pitfalls and Epidemiology European Journal of Heart Failure Nathaniel M. Hawkins, Mark C. Petrie et al. 402
16 Red Cell Distribution width has Incremental Prognostic Value to B-Type Natriuretic Peptide in Acute Heart Failure European Journal of Heart Failure Colette E. Jackson, Jonathan R. Dalzell et al. 50
17 Effects of the Oral Direct Renin Inhibitor Aliskiren in Patients With Symptomatic Heart Failure Circulation Heart Failure John J.V. McMurray, Bertram Pitt et al. 276
18 Prevalence and Prognostic Impact of Bundle Branch Block in Patients with Heart Failure: Evidence from the CHARM Programme European Journal of Heart Failure Nathaniel M. Hawkins, Duolao Wang et al. 45
19 Characterization of Health-Related Quality of Life in Heart Failure Patients with Preserved Versus Low Ejection Fraction in CHARM European Journal of Heart Failure Eldrin F. Lewis, Gervasio A. Lamas et al. 179
20 Previously Known and Newly Diagnosed Atrial Fibrillation: A Major Risk Indicator After a Myocardial Infarction Complicated by Heart Failure or Left Ventricular Dysfunction European Journal of Heart Failure Lars Køber, Karl Swedberg et al. 102

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026